Stay updated on Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Sign up to get notified when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changes from v3.7.1 to v3.7.2 while the study record page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T01:25:05.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The revision label in the page footer changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-11T01:54:44.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    A 403 Forbidden page is now displayed in place of the study record, presenting the standard error message and site chrome rather than the study details.
    Difference
    17%
    Check dated 2026-09-20T00:53:08.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    The revision tag on the page was updated from v3.6.5 to v3.6.6, replacing the previous revision. This reflects a minor platform update rather than changes to study details or data.
    Difference
    0.1%
    Check dated 2026-08-29T19:37:58.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page's revision label updates from v3.6.4 to v3.6.5, indicating a background site update; no changes to the study details are shown.
    Difference
    0.1%
    Check dated 2026-08-08T13:27:52.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a small internal update to the site's documentation or implementation.
    Difference
    0.1%
    Check dated 2026-07-25T06:26:49.000Z thumbnail image

Stay in the know with updates to Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety & Dose of Insulin Receptor MoAb-IDS in Hunter Syndrome Clinical Trial page.